Literature DB >> 17154345

Screening and analysis of the multiple absorbed bioactive components and metabolites of Dangguibuxue decoction by the metabolic fingerprinting technique and liquid chromatography/diode-array detection mass spectrometry.

Ping Wang1, Yizeng Liang, Neng Zhou, Benmei Chen, Lunzhao Yi, Yan Yu, Zhibiao Yi.   

Abstract

Based on the metabolic fingerprinting technique and liquid chromatography/diode array detection mass spectrometry (LC/DAD-MS), a method for rapid screening and analysis of the multiple absorbed bioactive components and metabolites of an oral solution of Dangguibuxue decoction (ODD) in rabbit plasma after oral administration of ODD was developed. The results obtained from a comprehensive comparative analysis of the fingerprints of the ODD and its metabolic fingerprints in rabbit plasma indicated that 46 components in the ODD were absorbed into the rabbit's body. Of them, ten components were tentatively identified from their MS and UV spectra and retention behaviors by comparing the results with the reported literature. They were calycosin-7-O-beta-D-glycoside, (6aR,-11aR)-hydroxy-9,10-dimethoxypterocarpan-3-O-beta-D-glycoside, ononin, L-3-hydroxy-9,10-dimethoxypterocarpan, formononetin, (3R)-7,2'-dihydroxy-3',4'-dimethoxyisoflavan, sedanenolide, E-ligustilide, Z-ligustilide, and Z-butylidenephthalide. In addition, 21 components were only found in the metabolic fingerprints, which suggested that they might be metabolites of some components in the ODD. The findings demonstrated that the proposed method could be used to rapidly and simultaneously analyze and screen the multiple absorbed bioactive constituents and metabolites in a formula of traditional Chinese medicines (TCMs) by comparing and contrasting the chromatographic fingerprints with its metabolic fingerprints. This is very important not only for the pharmaceutical discovery process and the quality control of crude drugs, but also to explain the curative mechanism of TCMs. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17154345     DOI: 10.1002/rcm.2816

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  6 in total

Review 1.  Emerging applications of metabolomics in studying chemopreventive phytochemicals.

Authors:  Lei Wang; Chi Chen
Journal:  AAPS J       Date:  2013-06-22       Impact factor: 4.009

2.  Sijunzi Decoction attenuates 2, 4, 6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in rats and ameliorates TNBS-induced claudin-2 damage via NF-κB pathway in Caco2 cells.

Authors:  Yue Lu; HanJie Lin; JinWei Zhang; JianAn Wei; Jing Sun; Ling Han
Journal:  BMC Complement Altern Med       Date:  2017-01-10       Impact factor: 3.659

3.  Comprehensive Identification of Guan-Xin-Shu-Tong Capsule via a Mass Defect and Fragment Filtering Approach by High Resolution Mass Spectrometry: In Vitro and In Vivo Study.

Authors:  Xun Gao; Jingqing Mu; Qing Li; Shaoyi Guan; Ran Liu; Yiyang Du; Huifen Zhang; Kaishun Bi
Journal:  Molecules       Date:  2017-06-16       Impact factor: 4.411

4.  Rapid Identification of the Multiple Absorbed Bioactive Components and Metabolites in Rat Serum after Oral Administration of Wu-Jia Sheng-Hua Capsule by UPLC-ESI-MS.

Authors:  Fang Geng; Fashan Wang; Taobo Zou; Kuiyuan Zhu; Wei Ma; Guanghui Tan; Ning Zhang
Journal:  J Anal Methods Chem       Date:  2013-05-14       Impact factor: 2.193

5.  Recent advances in the compound-oriented and pattern-oriented approaches to the quality control of herbal medicines.

Authors:  Zhongda Zeng; Foo-tim Chau; Hoi-yan Chan; Chui-yee Cheung; Tsui-yan Lau; Shuiyin Wei; Daniel Kam-wah Mok; Chi-on Chan; Yizeng Liang
Journal:  Chin Med       Date:  2008-08-04       Impact factor: 5.455

6.  Total Glucosides of Danggui Buxue Tang Attenuate BLM-Induced Pulmonary Fibrosis via Regulating Oxidative Stress by Inhibiting NOX4.

Authors:  Ping Zhao; Wen-Cheng Zhou; De-Lin Li; Xiao-Ting Mo; Liang Xu; Liu-Cheng Li; Wen-Hui Cui; Jian Gao
Journal:  Oxid Med Cell Longev       Date:  2015-08-11       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.